hydrazine has been researched along with Aplasia Pure Red Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cheng, L; He, G; He, Y; Hong, M; Li, J; Liu, X; Lu, R; Zhang, J; Zhang, R | 1 |
Fu, H; Gao, F; Gao, Y; Huang, H; Shi, J; Zhao, Y | 1 |
Aydin, S; Biale, L; Brunello, L; Bruno, B; Busca, A; Dellacasa, C; Festuccia, M; Giaccone, L; Godio, L; Manetta, S | 1 |
3 other study(ies) available for hydrazine and Aplasia Pure Red Cell
Article | Year |
---|---|
Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia.
Topics: Benzoates; Bone Marrow; Erythropoiesis; Humans; Hydrazines; Male; Middle Aged; Pyrazoles; Receptors, Thrombopoietin; Red-Cell Aplasia, Pure; Treatment Outcome | 2021 |
Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Benzoates; Blood Group Incompatibility; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Pyrazoles; Red-Cell Aplasia, Pure | 2021 |
Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.
Topics: ABO Blood-Group System; Allografts; Benzoates; Blood Group Incompatibility; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Male; Pyrazoles; Red-Cell Aplasia, Pure; Treatment Outcome | 2018 |